Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Edap Tms SA EDAP

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public... see more

Recent & Breaking News (NDAQ:EDAP)

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

GlobeNewswire 2 days ago

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire March 27, 2024

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

GlobeNewswire March 13, 2024

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

GlobeNewswire March 6, 2024

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

GlobeNewswire March 4, 2024

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

GlobeNewswire February 29, 2024

EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis

GlobeNewswire February 1, 2024

EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements

GlobeNewswire January 8, 2024

EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer

GlobeNewswire January 2, 2024

EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer

GlobeNewswire December 12, 2023

EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors

GlobeNewswire December 6, 2023

EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology

GlobeNewswire November 30, 2023

EDAP to Present at Piper Sandler's 35th Annual Healthcare Conference

GlobeNewswire November 20, 2023

EDAP Announces Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

EDAP to Present at the Jefferies London Healthcare Conference

GlobeNewswire November 6, 2023

EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023

GlobeNewswire October 26, 2023

EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference

GlobeNewswire September 6, 2023

EDAP Announces Second Quarter 2023 Financial Results

GlobeNewswire August 24, 2023

EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023  

GlobeNewswire August 10, 2023

EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer

GlobeNewswire July 26, 2023